Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7777]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Advances in treatment options for elderly cancer patients
Dr Ravindran Kanesvaran - National Cancer Centre Singapore, Singapore
Advances in treatment options for elderly cancer patients ( Dr Ravindran Kanesvaran - National Cancer Centre Singapore, Singapore )
19 Nov 2015
Four molecular subtypes identified in pancreatic cancer
Dr David Chang - University of Glasgow, Glasgow, UK
Four molecular subtypes identified in pancreatic cancer ( Dr David Chang - University of Glasgow, Glasgow, UK )
13 Nov 2015
NCRI 2015 highlights
Prof Charles Swanton - Cancer Research UK's London Research Institute, London...
NCRI 2015 highlights ( Prof Charles Swanton - Cancer Research UK's London Research Institute, London, UK )
13 Nov 2015
Prognostic value of BRAFV600 mutations in stage 3 cutaneous melanoma patients
Prof Philippe Saiag - University of Versailles, Versailles, France
Prognostic value of BRAFV600 mutations in stage 3 cutaneous melanoma patients ( Prof Philippe Saiag - University of Versailles, Versailles, France )
5 Nov 2015
Anti-PD1 or tyrosine kinase inhibitors?
Dr Mark Middleton - University of Oxford, Oxford, UK
Anti-PD1 or tyrosine kinase inhibitors? ( Dr Mark Middleton - University of Oxford, Oxford, UK )
5 Nov 2015
New drugs and new trials in melanoma
Prof Jean-Jacques Grob - Marseille University, Marseille, France
New drugs and new trials in melanoma ( Prof Jean-Jacques Grob - Marseille University, Marseille, France )
5 Nov 2015
Latest from the CoBRIM study
Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia
Latest from the CoBRIM study ( Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia )
5 Nov 2015
Anti-PD-1 or anti-CTLA-4 in first line therapy?
Prof Claus Garbe - University of Tübingen, Tübingen, Germany
Anti-PD-1 or anti-CTLA-4 in first line therapy? ( Prof Claus Garbe - University of Tübingen, Tübingen, Germany )
5 Nov 2015
Long response and long responders in melanoma immunology
Prof Georgina Long - University of Sydney, Sydney, Australia
Long response and long responders in melanoma immunology ( Prof Georgina Long - University of Sydney, Sydney, Australia )
5 Nov 2015
The Co-BRIM study: Quality-of-life assessment in patients with metastatic...
Prof Brigitte Dreno - Nantes University Hospital, Nantes, France
The Co-BRIM study: Quality-of-life assessment in patients with metastatic melanoma ( Prof Brigitte Dreno - Nantes University Hospital, Nantes, France )
5 Nov 2015
Progress in targeted therapy of melanoma
Prof Keith Flaherty - Massachusetts General Hospital, Boston, USA
Progress in targeted therapy of melanoma ( Prof Keith Flaherty - Massachusetts General Hospital, Boston, USA )
5 Nov 2015
Why is screening for melanoma important?
Prof Iris Zalaudek - Medical University of Graz, Graz, Austria
Why is screening for melanoma important? ( Prof Iris Zalaudek - Medical University of Graz, Graz, Austria )
5 Nov 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation